Citation(s)
- Blakytny R, Jude E
The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med. 2006 Jun;23(6):594-608. Review.
- Edwards JV, Howley PS
Human neutrophil elastase and collagenase sequestration with phosphorylated cotton wound dressings. J Biomed Mater Res A. 2007 Nov;83(2):446-54.
- Falanga V
The chronic wound: impaired healing and solutions in the context of wound bed preparation. Blood Cells Mol Dis. 2004 Jan-Feb;32(1):88-94. Review.
- Fasciglione GF, Marini S, D'Alessio S, Politi V, Coletta M
pH- and temperature-dependence of functional modulation in metalloproteinases. A comparison between neutrophil collagenase and gelatinases A and B. Biophys J. 2000 Oct;79(4):2138-49.
- Gelfand JM, Hoffstad O, Margolis DJ
Surrogate endpoints for the treatment of venous leg ulcers. J Invest Dermatol. 2002 Dec;119(6):1420-5.
- Gethin GT, Cowman S, Conroy RM
The impact of Manuka honey dressings on the surface pH of chronic wounds. Int Wound J. 2008 Jun;5(2):185-94. doi: 10.1111/j.1742-481X.2007.00424.x. Retraction in: Int Wound J. 2014 Jun;11(3):342.
- Greener B, Hughes AA, Bannister NP, Douglass J
Proteases and pH in chronic wounds. J Wound Care. 2005 Feb;14(2):59-61. Review.
- Kantor J, Margolis DJ
A multicentre study of percentage change in venous leg ulcer area as a prognostic index of healing at 24 weeks. Br J Dermatol. 2000 May;142(5):960-4.
- Karim RB, Brito BL, Dutrieux RP, Lassance FP, Hage JJ
MMP-2 assessment as an indicator of wound healing: A feasibility study. Adv Skin Wound Care. 2006 Jul-Aug;19(6):324-7.
- Keast DH, Bowering CK, Evans AW, Mackean GL, Burrows C, D'Souza L
MEASURE: A proposed assessment framework for developing best practice recommendations for wound assessment. Wound Repair Regen. 2004 May-Jun;12(3 Suppl):S1-17. Review.
- Lobmann R, Zemlin C, Motzkau M, Reschke K, Lehnert H
Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications. 2006 Sep-Oct;20(5):329-35.
- Margolis DJ, Gelfand JM, Hoffstad O, Berlin JA
Surrogate end points for the treatment of diabetic neuropathic foot ulcers. Diabetes Care. 2003 Jun;26(6):1696-700.
- Muller M, Trocme C, Lardy B, Morel F, Halimi S, Benhamou PY
Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Diabet Med. 2008 Apr;25(4):419-26. doi: 10.1111/j.1464-5491.2008.02414.x.
- Mustoe T
Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg. 2004 May;187(5A):65S-70S. Review.
- Nwomeh BC, Liang HX, Cohen IK, Yager DR
MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res. 1999 Feb;81(2):189-95.
- Pirayesh A, Dessy LA, Rogge FJ, Hoeksema HJ, Sinove YM, Dall' Antonia A, Jawad MA, Gilbert PM, Rubino C, Scuderi N, Blondeel R, Monstrey S
The efficacy of a polyhydrated ionogen impregnated dressing in the treatment of recalcitrant diabetic foot ulcers: a multi-centre pilot study. Acta Chir Belg. 2007 Nov-Dec;107(6):675-81.
- Ravanti L, Kähäri VM
Matrix metalloproteinases in wound repair (review). Int J Mol Med. 2000 Oct;6(4):391-407. Review.
- Robson MC, Hill DP, Woodske ME, Steed DL
Wound healing trajectories as predictors of effectiveness of therapeutic agents. Arch Surg. 2000 Jul;135(7):773-7.
- Rushton I
Understanding the role of proteases and pH in wound healing. Nurs Stand. 2007 Apr 18-24;21(32):68, 70, 72 passim. Review.
- Schmidtchen A, Wolff H, Hansson C
Differential proteinase expression by Pseudomonas aeruginosa derived from chronic leg ulcers. Acta Derm Venereol. 2001 Nov-Dec;81(6):406-9.
- Schönfelder U, Abel M, Wiegand C, Klemm D, Elsner P, Hipler UC
Influence of selected wound dressings on PMN elastase in chronic wound fluid and their antioxidative potential in vitro. Biomaterials. 2005 Nov;26(33):6664-73.
- Schultz G, Mozingo D, Romanelli M, Claxton K
Wound healing and TIME; new concepts and scientific applications. Wound Repair Regen. 2005 Jul-Aug;13(4 Suppl):S1-11. Review.
- Sheehan P, Jones P, Giurini JM, Caselli A, Veves A
Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Plast Reconstr Surg. 2006 Jun;117(7 Suppl):239S-244S.
- Smeets R, Ulrich D, Unglaub F, Wöltje M, Pallua N
Effect of oxidised regenerated cellulose/collagen matrix on proteases in wound exudate of patients with chronic venous ulceration. Int Wound J. 2008 Jun;5(2):195-203. doi: 10.1111/j.1742-481X.2007.00367.x.
- Steed DL, Hill DP, Woodske ME, Payne WG, Robson MC
Wound-healing trajectories as outcome measures of venous stasis ulcer treatment. Int Wound J. 2006 Mar;3(1):40-7.
- Steed DL
Wound-healing trajectories. Surg Clin North Am. 2003 Jun;83(3):547-55, vi-vii. Review.
- van Rossum M, Vooijs DP, Walboomers XF, Hoekstra MJ, Spauwen PH, Jansen JA
The influence of a PHI-5-loaded silicone membrane, on cutaneous wound healing in vivo. J Mater Sci Mater Med. 2007 Jul;18(7):1449-56. Epub 2007 Mar 27.
- Veves A, Sheehan P, Pham HT
A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg. 2002 Jul;137(7):822-7.
- Wysocki AB, Staiano-Coico L, Grinnell F
Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol. 1993 Jul;101(1):64-8.
- Xu L, McLennan SV, Lo L, Natfaji A, Bolton T, Liu Y, Twigg SM, Yue DK
Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care. 2007 Feb;30(2):378-80.
A Multi-centered, Prospective, Randomized, Double-blinded, Comparison of an Investigational Non-adherent Dressing to 3M Tegaderm Matrix Dressing With PHI Technology in the Management of Non-healing Diabetic Foot Ulcers
Details for clinical trial NCT01013792
